Frontlight ResearchEarly access
Trial site
Indiana University Simon Cancer Center
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Kidney cancer2 trials
- Lung cancer2 trials
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Endometrial cancer1 trial
- Mantle cell lymphoma1 trial
- Melanoma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 1/23 trials
- Phase 23 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting6 trials
- Completed3 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Indiana University3 trials
- Dartmouth-Hitchcock Medical Center1 trial
- International Myeloma Foundation1 trial
- Kahr Medical1 trial
- Karyopharm Therapeutics Inc1 trial
- and 4 more
Running trials
Active, not recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Recruiting
Active, not recruiting
Active, not recruiting
A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors
Recruiting
Active, not recruiting
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
Active, not recruiting
Active, not recruiting
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026